Strategic Blueprint LLC Has $2.74 Million Stake in Danaher Corporation $DHR

Strategic Blueprint LLC decreased its holdings in Danaher Corporation (NYSE:DHR) by 7.4% in the 2nd quarter, Holdings Channel.com reports. The firm owned 13,887 shares of the conglomerate’s stock after selling 1,112 shares during the period. Strategic Blueprint LLC’s holdings in Danaher were worth $2,743,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also bought and sold shares of the business. Capital Investment Services of America Inc. raised its stake in Danaher by 0.9% in the 2nd quarter. Capital Investment Services of America Inc. now owns 134,533 shares of the conglomerate’s stock worth $26,576,000 after purchasing an additional 1,242 shares in the last quarter. OLD Point Trust & Financial Services N A increased its holdings in Danaher by 24.9% in the 2nd quarter. OLD Point Trust & Financial Services N A now owns 1,406 shares of the conglomerate’s stock valued at $278,000 after buying an additional 280 shares during the period. Forum Financial Management LP increased its holdings in Danaher by 29.8% in the 2nd quarter. Forum Financial Management LP now owns 10,200 shares of the conglomerate’s stock valued at $2,015,000 after buying an additional 2,340 shares during the period. Ethic Inc. increased its holdings in Danaher by 7.5% in the 2nd quarter. Ethic Inc. now owns 65,613 shares of the conglomerate’s stock valued at $13,044,000 after buying an additional 4,552 shares during the period. Finally, Parcion Private Wealth LLC bought a new position in Danaher in the 2nd quarter valued at about $236,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Insiders Place Their Bets

In other Danaher news, Director Teri List sold 2,778 shares of the business’s stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the sale, the director directly owned 20,751 shares of the company’s stock, valued at $4,379,706.06. The trade was a 11.81% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 11.10% of the stock is owned by insiders.

Danaher Trading Up 2.1%

Shares of Danaher stock opened at $222.62 on Friday. The firm has a market capitalization of $157.25 billion, a PE ratio of 45.90, a price-to-earnings-growth ratio of 3.31 and a beta of 0.77. The company has a current ratio of 1.52, a quick ratio of 1.22 and a debt-to-equity ratio of 0.33. The firm’s 50 day moving average is $202.49 and its 200 day moving average is $198.02. Danaher Corporation has a 1 year low of $171.00 and a 1 year high of $258.23.

Danaher (NYSE:DHR) last posted its earnings results on Tuesday, October 21st. The conglomerate reported $1.89 earnings per share for the quarter, topping analysts’ consensus estimates of $1.72 by $0.17. Danaher had a net margin of 14.44% and a return on equity of 10.92%. The firm had revenue of $6.05 billion for the quarter, compared to analyst estimates of $6 billion. During the same period in the previous year, the firm posted $1.71 EPS. The company’s revenue for the quarter was up 4.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Equities research analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be issued a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date of this dividend is Friday, September 26th. Danaher’s payout ratio is presently 27.23%.

Analyst Upgrades and Downgrades

Several equities analysts have commented on the stock. Redburn Partners set a $220.00 target price on shares of Danaher in a report on Wednesday, October 8th. Rothschild & Co Redburn reissued a “neutral” rating and issued a $220.00 target price (down from $245.00) on shares of Danaher in a report on Wednesday, October 8th. Scotiabank raised shares of Danaher from a “sector perform” rating to a “sector outperform” rating and set a $275.00 target price on the stock in a report on Friday, July 11th. JPMorgan Chase & Co. raised their target price on shares of Danaher from $260.00 to $270.00 and gave the company an “overweight” rating in a report on Wednesday. Finally, Evercore ISI lifted their price target on shares of Danaher from $226.00 to $245.00 and gave the company an “outperform” rating in a report on Tuesday, October 7th. Eighteen research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $243.39.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.